Clinical Trials Directory

Trials / Completed

CompletedNCT04008914

Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
492 (actual)
Sponsor
Ascension Macomb-Oakland Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Detailed description

Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.

Conditions

Interventions

TypeNameDescription
OTHERretrospective observationRetrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Timeline

Start date
2017-08-01
Primary completion
2018-03-01
Completion
2019-01-18
First posted
2019-07-05
Last updated
2019-07-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04008914. Inclusion in this directory is not an endorsement.